{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:32:28Z","timestamp":1788849148718,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.neuro.2014.10.004","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T03:04:22Z","timestamp":1413428662000},"page":"139-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: Mitochondrial dysfunction and neurodegeneration"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1734-4443","authenticated-orcid":false,"given":"Ashwini","family":"Hariharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trupti","family":"Shirole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti G.","family":"Jagtap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2014.10.004_bib0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3797\/scipharm.1203-06","article-title":"Chronic inhibition of central angiotensin-converting enzyme ameliorates colchicine-induced memory impairment in mice","volume":"80","author":"Awasthi","year":"2012","journal-title":"Sci Pharm"},{"key":"10.1016\/j.neuro.2014.10.004_bib0275","article-title":"Huntington disease: pathophysiology and diagnosis","author":"Bordelon","year":"2012","journal-title":"Med Educ Neurol Neurosurg"},{"key":"10.1016\/j.neuro.2014.10.004_bib0035","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Brouillet","year":"1993","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.10.004_bib0045","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2014.10.004_bib0050","series-title":"Histological technique","author":"Carelton","year":"1967"},{"issue":"3","key":"10.1016\/j.neuro.2014.10.004_bib0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","article-title":"Loss of normal huntingtin function: new developments in Huntington's disease research","volume":"24","author":"Cattaneo","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuro.2014.10.004_bib0055","first-page":"135","article-title":"Mitochondrial dysfunction metabolic deficits, and increased oxidative stress in Huntington's disease","volume":"34","author":"Chen","year":"2011","journal-title":"Med J"},{"key":"10.1016\/j.neuro.2014.10.004_bib0245","first-page":"669","article-title":"Tetrabenazine in Huntington's disease chorea","volume":"1","author":"Chitnis","year":"2009","journal-title":"Clin Med Ther"},{"key":"10.1016\/j.neuro.2014.10.004_bib0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2478\/v10011-011-0009-3","article-title":"Inhibition of central angiotensin converting enzyme exerts anxiolytic effects by decreasing brain oxidative stress","volume":"30","author":"Ciobica","year":"2011","journal-title":"J Med Biochem"},{"issue":"6","key":"10.1016\/j.neuro.2014.10.004_bib0065","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1159\/000107757","article-title":"From mitochondria to disease: role of the renin-angiotensin system","volume":"27","author":"de Cavanagh","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.neuro.2014.10.004_bib0005","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCRESAHA.107.162800","article-title":"Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction","volume":"102","author":"Doughan","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.neuro.2014.10.004_bib0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"New and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharamcol"},{"key":"10.1016\/j.neuro.2014.10.004_bib0060","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1093\/brain\/awh278","article-title":"Trinucleotide repeats and neurodegenerative disease","volume":"127","author":"Everett","year":"2004","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neuro.2014.10.004_bib0265","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.expneurol.2011.05.024","article-title":"Bioenergetic dysfunction in Huntington's disease human cybrids","volume":"231","author":"Ferreira","year":"2011","journal-title":"Exp Neurol"},{"issue":"12","key":"10.1016\/j.neuro.2014.10.004_bib0145","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","article-title":"Calpain activation in Huntington's disease","volume":"22","author":"Gafni","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.10.004_bib0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Ann Biochem"},{"key":"10.1016\/j.neuro.2014.10.004_bib0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0306-4522(96)00602-1","article-title":"Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid","volume":"79","author":"Hantraye","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.10.004_bib0090","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/ajcp\/17.9_ts.750","article-title":"Simultaneous histologic fixation and gross determination of calcification","volume":"17","author":"Hartz","year":"1974","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.neuro.2014.10.004_bib0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneumeth.2006.07.006","article-title":"Use of the Narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease","volume":"159","author":"Henderson","year":"2007","journal-title":"J Neurosci Methods"},{"issue":"6","key":"10.1016\/j.neuro.2014.10.004_bib0105","first-page":"2025","article-title":"HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice","volume":"118","author":"Hisatomi","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuro.2014.10.004_bib0040","first-page":"S860","article-title":"Comparative effects of captopril, losartan and PD123319 on the memory processes in rats","volume":"24","author":"Hritcu","year":"2009","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.neuro.2014.10.004_bib0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-2999(91)90125-A","article-title":"Utility of an elevated plus-maze for dissociation of amnesic and behavioural effects of drugs in mice","volume":"194","author":"Itoh","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2014.10.004_bib0150","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10571-008-9270-5","article-title":"Mitochondrial oxidative stress and dysfunction in rat brain induced by carbofuran exposure","volume":"28","author":"Kamboj","year":"2008","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.neuro.2014.10.004_bib0155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0076-6879(67)10061-X","article-title":"Preparation of succinate dehydrogenase and reconstitution of succinate oxidase","volume":"10","author":"King","year":"1967","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.neuro.2014.10.004_bib0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0076-6879(67)10055-4","article-title":"Preparations and properties of soluble NADH dehydrogenases from cardiac muscle","volume":"10","author":"King","year":"1967","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.neuro.2014.10.004_bib0020","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.fct.2009.07.011","article-title":"Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism","volume":"47","author":"Kumar","year":"2009","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.neuro.2014.10.004_bib0205","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbr.2009.08.028","article-title":"Protective effect of hesperidin and Naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide","volume":"206","author":"Kumar","year":"2010","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.neuro.2014.10.004_bib0130","first-page":"226","article-title":"Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease","volume":"1","author":"Labandeira-Garcia","year":"2012","journal-title":"Am J Neurodegener Dis"},{"key":"10.1016\/j.neuro.2014.10.004_bib0140","first-page":"128","article-title":"The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration","volume":"1","author":"Leegwater-Kim","year":"2004","journal-title":"J Am Soc Exp Neurother"},{"key":"10.1016\/j.neuro.2014.10.004_bib0165","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jnr.20598","article-title":"Angiotensin-reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism","volume":"81","author":"Lopez-Real","year":"2005","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.1016\/j.neuro.2014.10.004_bib0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2014.10.004_bib0175","series-title":"Catalase: methods of enzymatic analysis","first-page":"885","author":"Luck","year":"1971"},{"key":"10.1016\/j.neuro.2014.10.004_bib0190","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1212\/WNL.23.9.912","article-title":"Choline acetylase and glutamic acid decarboxylase in Huntington's chorea \u2013 a preliminary study","volume":"9","author":"McGeer","year":"1973","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2014.10.004_bib0135","series-title":"Design and synthesis of inhibitors targeting the aspartic proteases HIV-1 PR and BACE-1","author":"Meredith","year":"2009"},{"key":"10.1016\/j.neuro.2014.10.004_bib0085","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.jhh.1001613","article-title":"Influence of losartan and atenololon memory function in very elderly hypertensive patients","volume":"17","author":"Mugellini","year":"2003","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.neuro.2014.10.004_bib0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2013\/136028","article-title":"The brain renin-angiotensin system and mitochondrial function: influence on blood pressure and baroreflex in transgenic rat strains","volume":"2013","author":"Nautiyal","year":"2013","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.neuro.2014.10.004_bib0010","series-title":"The Role of Mitochondrial Dysfunction in Neurodegenerative Proteinopathies and Aging","author":"Ocampo","year":"2012"},{"key":"10.1016\/j.neuro.2014.10.004_bib0195","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohini","year":"1979","journal-title":"Anal Biochem"},{"issue":"1999","key":"10.1016\/j.neuro.2014.10.004_bib0095","first-page":"153","article-title":"Presentdata concerning the renin-angiotensin system of extrarenal origin","volume":"36","author":"Petrescu","year":"1999","journal-title":"Rom J Physiol"},{"key":"10.1016\/j.neuro.2014.10.004_bib0200","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00109-008-0331-5","article-title":"Brain renin angiotensin in disease","volume":"86","author":"Phillips","year":"2008","journal-title":"J Mol Med"},{"issue":"5","key":"10.1016\/j.neuro.2014.10.004_bib0235","first-page":"359","article-title":"Huntington's disease: pathogenesis diagnosis and treatment","volume":"19","author":"Purdon","year":"1994","journal-title":"J Psychiatr Neurosci"},{"issue":"4","key":"10.1016\/j.neuro.2014.10.004_bib0250","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ilar.48.4.356","article-title":"Animal models of Huntington's disease","volume":"48","author":"Ramaswamy","year":"2007","journal-title":"ILAR J"},{"key":"10.1016\/j.neuro.2014.10.004_bib0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0006-8993(98)00419-3","article-title":"Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizociline induced leaning impairment","volume":"799","author":"Reddy","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2014.10.004_bib0220","first-page":"1","article-title":"Huntington's disease: a clinical review","author":"Roos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neuro.2014.10.004_bib0215","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.neuint.2010.07.005","article-title":"Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system","volume":"57","author":"Sandhir","year":"2010","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuro.2014.10.004_bib0240","first-page":"351","article-title":"Estimation of total and non-protein sulfydral groups in tissues with Ellman's reagent","volume":"95","author":"Sedlak","year":"1979","journal-title":"Anal Biochem"},{"key":"10.1016\/j.neuro.2014.10.004_bib0255","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1083\/jcb.32.2.415","article-title":"An electron-transport system associated with the outer membrane of liver mitochondria \u2013 a biochemical and morphological study","volume":"32","author":"Sottocasa","year":"1967","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neuro.2014.10.004_bib0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2014.10.004_bib0230","doi-asserted-by":"crossref","first-page":"0024","DOI":"10.1016\/0024-3205(96)00527-9","article-title":"Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice","volume":"59","author":"Takai","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.neuro.2014.10.004_bib0110","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/molecules15020878","article-title":"3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past present and future","volume":"15","author":"T\u00fanez","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.neuro.2014.10.004_bib0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","author":"Uttara","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.neuro.2014.10.004_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(98)00078-3","article-title":"Learning and anxiety in angiotensin-deficient mice","volume":"100","author":"Walther","year":"1999","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuro.2014.10.004_bib0210","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/brain\/120.9.1569","article-title":"Cortical control of movement in Huntington's disease: A PET activation study","volume":"120","author":"Weeks","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.neuro.2014.10.004_bib0125","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fendo.2013.00158","article-title":"A role for the brain RAS in Alzheimer's and Parkinson's diseases","volume":"4","author":"Wright","year":"2013","journal-title":"Front Endocrinol"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X14001727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X14001727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:16:27Z","timestamp":1758982587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X14001727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":54,"alternative-id":["S0161813X14001727"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2014.10.004","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: Mitochondrial dysfunction and neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2014.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}